Skip to main content
SPRO logo

SPRO

Spero Therapeutics, Inc.
$2.20 -0.02 (-0.90%) At close · Jul 2
Market Cap
$127.38M
Shares
57,901,493

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 50
Total Value: $48,712,323
Total Shares: 20,817,241

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 50 13F filers · Δ vs Dec 31, 2025
Top Holder
44.1%
Jun 2023 → Mar 2026 · range 20.8% – 44.1%
+0.9 pts
Top 5
74.1%
Jun 2023 → Mar 2026 · range 57.3% – 74.4%
−0.3 pts
Top 10
87.0%
Jun 2023 → Mar 2026 · range 78.3% – 89.4%
+1.1 pts
HHI
2,253
Jun 2023 → Mar 2026 · range 997 – 2,253
Moderately concentrated+67

Quarterly Activity

vs Dec 31, 2025
New
8
Increased
12
Decreased
11
Sold Out
14
Unchanged
19
Holder count: -6
Institutional value: -1.5%
Shares held: -1.9%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 55 of 55
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1701108 CUSIP 84833T103 Visit website Investor relations